Patent ID: 8623073

Claim:
A stent, comprising: a) a degradable metal stent body having an external abluminal side, an internal luminal side and two connecting sides connecting the abluminal side to the luminal side; b) a partition layer which is applied to the surface of the stent main body so that at least part of the abluminal side and at least part of each but not the entirety of both of the two connecting sides are covered, and wherein at least part of the surface of the luminal side is not covered; and c) an agent-containing layer which is applied to the surface of the partition layer at least partially on the abluminal side and the two connecting sides of the stent main body, the agent-containing layer comprising one or more agents, the agent-containing layer being substantially not in direct contact with the stent main body, wherein the degradation products of the agent-containing layer and the degradation products of the stent main body are spatially separated by the partition layer so as to minimize any pH-lower effect of the degradation products of the stent main body on the degradation products of the agent-containing layer, and wherein the agent is suitable for at least one of prophylaxis, therapy of in-stent restenosis, and tissue inflammation.